Overview

Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study will investigate the bioequivalence and compare the safety profiles following inhalation of Vantobra to TOBI nebulizer solution in healthy subjects. Bioequivalence will be investigated based on the pharmacokinetic plasma profiles of Vantobra nebulizer solution compared to TOBI nebulizer solution.
Phase:
Phase 1
Details
Lead Sponsor:
Pari Pharma GmbH
Treatments:
Tobramycin